1. Home
  2. People
  3. Fang, Niki

Niki Fang

Partner

San Francisco

Niki Fang concentrates her corporate practice on representing issuers and underwriters in public offerings and capital markets transactions.

Niki also regularly counsels public and late-stage private companies on securities law compliance, disclosure matters, SEC reporting obligations, corporate governance and stock exchange listing obligations. In addition, Niki’s practice includes venture capital financings and advising start-up companies on general corporate matters. She represents a wide range of technology and life sciences companies, from privately held start-ups to publicly traded corporations.

Prior to joining Orrick, Niki was at Fenwick & West LLP and Davis Polk & Wardwell LLP.

  • A representative listing of Niki’s recent transactions include: 

    • Genenta Science S.p.A on the registered direct offering of $15 million of American Depositary Shares
    • TransCode on its acquisition of Polynoma LLC
    • BioAtla on its $75 million PIPE offering, its $65 million underwritten offering, the establishment of its up to $100 million at the market offering and its $9.2 million registered direct offering
    • Virios Therapeutics, Inc. in its combination with Wex Pharmaceuticals, Inc. in an all-stock transaction to form Dogwood Therapeutics, Inc. (Nasdaq: DWTX)
    • Onconova Therapeutics, Inc.in its combination with Trawsfynydd Therapeutics, Inc. in an all-stock transaction
    • Ipsen on its acquisition of Albireo Pharma Inc, and related tender offer
    • DURECT Corporation on its $10 million registered direct offering
    • Getaround, a connected carsharing marketplace, on its business combination with InterPrivate II Acquisition Corp.
    • Weave Communications on its $120 million initial public offering
    • Underwriters led by Morgan Stanley, J.P. Morgan, and BofA Securities on the $1 billion initial public offering of Freshworks
    • Asana, Inc. on its direct listing on the New York Stock Exchange and related $450 million senior mandatory convertible promissory note financing
    • Clover Health Investments, Corp., a next-generation Medicare Advantage insurer, on its business combination with Social Capital Hedosophia Holdings Corp. III
    • Sonos on its $95.8 million initial public offering
    • Redfin on its $258.3 million concurrent public offerings of common stock and convertible notes
    • Cloudera on its $258.8 million initial public offering, its $254 million follow-on offering and its $5.2 billion merger with Hortonworks
    • Chegg on its $155.3 million follow-on offering
    • GoPro on its $175 million convertible senior notes offering
    • Workday in various transactions including its $732.5 million initial public offering, its $534 million follow-on offering and its $1 billion convertible senior notes offering
    • Castlight Health on its $204 million initial public offering
    • Gridsum Holdings on its $100 million initial public offering
    • Aeglea Biotherapeutics on its $54.8 million initial public offering
    • BioPharmx on its $10 million public offering and simultaneous uplisting to NYSE American and its $11 million follow-on offering
    • Adesto Technologies on its $17.5 million and $40.2 million follow-on offerings
    • Underwriters led by Morgan Stanley and Goldman Sachs on the $100 million initial public offering of MobileIron
    • Underwriters led by Morgan Stanley, J.P. Morgan and BofA Merrill Lynch on the $86 million initial public offering of Barracuda Networks
    • Silver Spring Networks on its $830 million acquisition by Itron

Insights

Events

News